- Home
- NPWR vs XGN Comparison
NPWR vs XGN Comparison
Compare NPWR & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- XGN
- Stock Information
- Founded
- NPWR 2010
- XGN 2002
- Country
- NPWR United States
- XGN United States
- Employees
- NPWR N/A
- XGN N/A
- Industry
- NPWR Industrial Machinery/Components
- XGN Medical Specialities
- Sector
- NPWR Energy
- XGN Health Care
- Exchange
- NPWR Nasdaq
- XGN Nasdaq
- Market Cap
- NPWR 285.1M
- XGN 253.9M
- IPO Year
- NPWR N/A
- XGN 2019
- Fundamental
- Price
- NPWR $3.82
- XGN $11.73
- Analyst Decision
- NPWR Buy
- XGN Strong Buy
- Analyst Count
- NPWR 2
- XGN 6
- Target Price
- NPWR $4.00
- XGN $12.83
- AVG Volume (30 Days)
- NPWR 2.7M
- XGN 234.3K
- Earning Date
- NPWR 11-13-2025
- XGN 11-04-2025
- Dividend Yield
- NPWR N/A
- XGN N/A
- EPS Growth
- NPWR N/A
- XGN N/A
- EPS
- NPWR N/A
- XGN N/A
- Revenue
- NPWR $12,000.00
- XGN $58,862,000.00
- Revenue This Year
- NPWR N/A
- XGN $22.50
- Revenue Next Year
- NPWR N/A
- XGN $14.19
- P/E Ratio
- NPWR N/A
- XGN N/A
- Revenue Growth
- NPWR N/A
- XGN 3.89
- 52 Week Low
- NPWR $1.48
- XGN $2.38
- 52 Week High
- NPWR $14.28
- XGN $12.23
- Technical
- Relative Strength Index (RSI)
- NPWR 53.85
- XGN 63.55
- Support Level
- NPWR $3.42
- XGN $11.58
- Resistance Level
- NPWR $4.32
- XGN $12.23
- Average True Range (ATR)
- NPWR 0.47
- XGN 0.31
- MACD
- NPWR -0.05
- XGN -0.04
- Stochastic Oscillator
- NPWR 30.30
- XGN 66.90
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.